反応式
[CH3:1][O:2][C:3]1[CH:30]=[C:29]([O:31][CH3:32])[CH:28]=[CH:27][C:4]=1[C:5]([N:7]1[CH2:11][CH2:10][C:9]([CH2:20][CH2:21]CS([O-])(=O)=O)([C:12]2[CH:17]=[CH:16][C:15]([Cl:18])=[C:14]([Cl:19])[CH:13]=2)[CH2:8]1)=[O:6].Cl.[C:34]1([C:40]2([C:46]([NH2:48])=[O:47])[CH2:45][CH2:44][NH:43][CH2:42][CH2:41]2)[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=1.C(=O)([O-])[O-].[K+].[K+].O>C1COCC1>[Cl:19][C:14]1[CH:13]=[C:12]([C:9]2([CH2:20][CH2:21][N:43]3[CH2:42][CH2:41][C:40]([C:34]4[CH:35]=[CH:36][CH:37]=[CH:38][CH:39]=4)([C:46]([NH2:48])=[O:47])[CH2:45][CH2:44]3)[CH2:10][CH2:11][N:7]([C:5](=[O:6])[C:4]3[CH:27]=[CH:28][C:29]([O:31][CH3:32])=[CH:30][C:3]=3[O:2][CH3:1])[CH2:8]2)[CH:17]=[CH:16][C:15]=1[Cl:18]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
2-[1-(2,4-Dimethoxy-benzoyl)-3-(3,4-dichloro-phenyl)-pyrrolidin-3-yl]-ethyl-methanesulfonate (343 mg, 0.68 mmol) was dissolved in THF (8 mL) and the 4-phenyl-piperidine-4-carboxylic acid amide hydrochloride (170 mg, 0.71 mmol, 1.04 eq.), potassium carbonate (200 mg, 1.45 mmol, 2.1 eq.), and water (2 mL) were added and the solution was heated at reflux for 16 hours. The solution was concentrated in vacuo and the aqueous phase was extracted with dichloromethane, dried over magnesium sulfate, filtered, and concentrated in vacuo. The residue was chromatographed on silica gel (40 g) with a gradient of ethyl acetate to 6% methanol in dichloromethane to give 151 mg (36%) of the title compound.
後処理
- temperaturethe solution was heated
- temperatureat reflux for 16 hours
- concentrationThe solution was concentrated in vacuo
- extractionthe aqueous phase was extracted with dichloromethane
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was chromatographed on silica gel (40 g) with a gradient of ethyl acetate to 6% methanol in dichloromethane
出典と根拠
- ORDレコード
- ord-7bb48001271a4aa088cae18790e56ed0
- 出典データセット
- uspto-grants-1997_07
- 特許番号
- US05648366
関連ノート
読み込み中…